Attorney General Dustin McDaniel said today he will file a petition asking the Arkansas Supreme Court to reconsider its recent ruling reversing a judgment of more than $1 billion against Johnson & Johnson regarding the marketing of the anti-psychotic drug Risperdal, the AP reports.
In 2012, in a major victory for McDaniel at the time, the state was awarded $1.2 billion after the company was found to have misled doctors and patients about dangerous side effects of the drug. The money was slated to go into a trust fund for the private option. However, in March, the Supreme Court reversed the verdict, eliminating the windfall for the state.
By the way, according to trial testimony, J & J accrued nearly $30 billion in net profits on Risperdal between 1994 and 2010.